Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4601–4650 of 75371
Mr. Hurlston will succeed Alan Lowe, the Company’s President and Chief Executive Officer, who is stepping down as President and CEO effective as of immediately prior to 12:00 a.m. Pacific Time on February 7, 2025.
Pursuant to the Plan, effective as of the close of business on the Effective Date, Carlos A. de Solo, Kevin Berg, Edward J. Borkowski, Bryan Cho, Ralph De La Torre, M.D., Dr. Vincent Omachonu, Ryan O’Quinn and Jose R. Rodriguez ceased to be directors of the Company.
In addition, effective as of the close of business on the Effective Date, Carlos de Solo, Chief Executive Officer of the Company, Alberto de Solo, Chief Operating Officer of the Company, Kevin Wirges, Chief Financial Officer of the Company and Paul Rundell, Chief Restructuring Officer of the Company, ceased to be officers of the Company.
In addition, effective as of the close of business on the Effective Date, Carlos de Solo, Chief Executive Officer of the Company, Alberto de Solo, Chief Operating Officer of the Company, Kevin Wirges, Chief Financial Officer of the Company and Paul Rundell, Chief Restructuring Officer of the Company, ceased to be officers of the Company.
Pursuant to the Plan, effective as of the close of business on the Effective Date, Carlos A. de Solo, Kevin Berg, Edward J. Borkowski, Bryan Cho, Ralph De La Torre, M.D., Dr. Vincent Omachonu, Ryan O’Quinn and Jose R. Rodriguez ceased to be directors of the Company.
Pursuant to the Plan, effective as of the close of business on the Effective Date, Carlos A. de Solo, Kevin Berg, Edward J. Borkowski, Bryan Cho, Ralph De La Torre, M.D., Dr. Vincent Omachonu, Ryan O’Quinn and Jose R. Rodriguez ceased to be directors of the Company.
Pursuant to the Plan, effective as of the close of business on the Effective Date, Carlos A. de Solo, Kevin Berg, Edward J. Borkowski, Bryan Cho, Ralph De La Torre, M.D., Dr. Vincent Omachonu, Ryan O’Quinn and Jose R. Rodriguez ceased to be directors of the Company.
In addition, effective as of the close of business on the Effective Date, Carlos de Solo, Chief Executive Officer of the Company, Alberto de Solo, Chief Operating Officer of the Company, Kevin Wirges, Chief Financial Officer of the Company and Paul Rundell, Chief Restructuring Officer of the Company, ceased to be officers of the Company.
Pursuant to the Plan, effective as of the close of business on the Effective Date, Carlos A. de Solo, Kevin Berg, Edward J. Borkowski, Bryan Cho, Ralph De La Torre, M.D., Dr. Vincent Omachonu, Ryan O’Quinn and Jose R. Rodriguez ceased to be directors of the Company.
Pursuant to the Plan, effective as of the close of business on the Effective Date, Carlos A. de Solo, Kevin Berg, Edward J. Borkowski, Bryan Cho, Ralph De La Torre, M.D., Dr. Vincent Omachonu, Ryan O’Quinn and Jose R. Rodriguez ceased to be directors of the Company.
In addition, effective as of the close of business on the Effective Date, Carlos de Solo, Chief Executive Officer of the Company, Alberto de Solo, Chief Operating Officer of the Company, Kevin Wirges, Chief Financial Officer of the Company and Paul Rundell, Chief Restructuring Officer of the Company, ceased to be officers of the Company.
Pursuant to the Plan, effective as of the close of business on the Effective Date, Carlos A. de Solo, Kevin Berg, Edward J. Borkowski, Bryan Cho, Ralph De La Torre, M.D., Dr. Vincent Omachonu, Ryan O’Quinn and Jose R. Rodriguez ceased to be directors of the Company.
On January 31, 2025, J. Eric Smith, a member of the Company’s board of directors, notified the Company that he was resigning from his role as a director of the Company.
(ii) Luvleen Sidhu, Ajay Asija, and Warren Taylor each resigned as officers
(i) Luvleen Sidhu, John Dolan, Mike Gill, Brent Hurley, Michael Pavone, Aaron Hodari, and Marcy Schwab each resigned from the board of directors
(ii) Luvleen Sidhu, Ajay Asija, and Warren Taylor each resigned as officers
(i) Luvleen Sidhu, John Dolan, Mike Gill, Brent Hurley, Michael Pavone, Aaron Hodari, and Marcy Schwab each resigned from the board of directors
(i) Luvleen Sidhu, John Dolan, Mike Gill, Brent Hurley, Michael Pavone, Aaron Hodari, and Marcy Schwab each resigned from the board of directors
(i) Luvleen Sidhu, John Dolan, Mike Gill, Brent Hurley, Michael Pavone, Aaron Hodari, and Marcy Schwab each resigned from the board of directors
(ii) Luvleen Sidhu, Ajay Asija, and Warren Taylor each resigned as officers
(i) Luvleen Sidhu, John Dolan, Mike Gill, Brent Hurley, Michael Pavone, Aaron Hodari, and Marcy Schwab each resigned from the board of directors
(i) Luvleen Sidhu, John Dolan, Mike Gill, Brent Hurley, Michael Pavone, Aaron Hodari, and Marcy Schwab each resigned from the board of directors
(i) Luvleen Sidhu, John Dolan, Mike Gill, Brent Hurley, Michael Pavone, Aaron Hodari, and Marcy Schwab each resigned from the board of directors
Ryan Weige, the Company’s Grain Merchandiser, was terminated by the Company and hired by a subsidiary of Gevo.
Mr. Crenshaw will replace Westervelt T. “Westy” Ballard, Jr., who has mutually agreed with the Company to terminate his employment as the Company’s President and Chief Executive Officer and to resign his position as a director.
On January 29, 2025 (the “ Separation Date ”), Lourie Zak resigned as Chief Financial Officer of Genelux Corporation (the “ Company ”), effective immediately.
On January 29, 2025, Christopher Sambar notified the Board of Directors (the “Board”) of AST SpaceMobile, Inc. (the “Company”) of his decision to resign as the designee of AT&T Venture Investments, LLC (“AT&T”) from the Board, effective on the same date.
On January 31, 2025, Shelley Webb, Chief Legal & People Officer of PagerDuty, Inc. (the “Company”), notified the Company of her decision to resign from the Company effective February 3, 2025.
Mr. Horlock’s employment shall terminate effective February 28, 2025.
In accordance with the terms and conditions of the Purchase Agreement, effective as of the Closing Date, Chris Toth ceased serving as Executive Vice President and Group President, Kidney Care, and as an executive officer of the Company.
On January 28, 2025, Michael Hurlston notified the Company of his resignation from his position as President and Chief Executive Officer and from the board of directors (the “Board”) of the Company, effective February 3, 2025, to pursue another opportunity.
Jeffrey Maggioncalda, our former President, Chief Executive Officer ( “CEO” ), and a Class III director, in connection with his previously disclosed retirement from those roles effective as of February 3, 2025
On February 1, 2025, Myles Kleeger informed Braze, Inc. (the “Company”) of his intention to resign as President and Chief Commercial Officer of the Company, effective June 1, 2025
Following the appointment of Ms. Calero, Rodolfo Guerrero Angulo resigned as an executive officer and a director of the Company
and Marquez Hernandez Maria De Lourdes resigned as a director of the Company.
Mr. Scott Contino will resign as the Company’s Interim Chief Financial Officer and Principal Financial Officer.
As previously disclosed, Tania Secor, the former Chief Financial Officer of Integral Ad Science Holding Corp. (the “Company”) departed the Company on January 3, 2025.
Effective January 31, 2025, Karthik Sridharan, Senior Executive Vice President and Chief Operations and Technology Officer of Fulton Financial Corporation ("Fulton"), will be leaving Fulton.
On January 30, 2025, Robert Chapek notified the Board of Directors (the “Board”) of Masimo Corporation (“Masimo”) of his irrevocable resignation from the Board and all committees thereof, effective as of the date of the 2025 annual meeting of Masimo, which date the Board has not determined at this time.
On January 29, 2025, the Company notified Salvatore D. Orsini, the Company’s Chief Procurement Officer, that his position was being eliminated resulting in the termination of his employment with the Company, effective February 28, 2025.
On January 27, 2025, Bank First Corporation (the “Company”) announced that its Senior Vice President of Operations, Kristeen Pelot, has resigned from her position at the Company and its wholly owned banking subsidiary, Bank First, N.A.
it was determined that Rick Dillon, Executive Vice President and Chief Financial Officer, will leave the Company, effective February 14, 2025.
Timothy Donovan, Executive Vice President, Chief Legal Officer and General Counsel, notified Vestis Corporation (the “ Company ”) of his retirement to be effective February 14, 2025.
Cassan Pancham, Executive Vice President and Business Group Executive, will retire from his position at the Corporation effective May 15, 2025.
On January 27, 2025, Paul Ney, the Chief Legal Officer and Corporate Secretary of Momentus Inc. (the “Company”), tendered his resignation from the Company, effective as of January 28, 2025, to join the Trump Administration and serve as the Deputy Counsel to the President for National Security Affairs and National Security Council Legal Advisor.
On January 27, 2025, the Company and Dr. Algranati entered into a Separation and General Release Agreement (the "Separation Agreement"), pursuant to which Dr. Algranati's employment with the Company will end on February 1, 2025 (the "Separation Date").
On January 28, 2025, Ronald E. Blaylock, a member of the board of directors (the “Board”) of CarMax, Inc. (the “Company”), informed the Company that he would not stand for reelection as a member of the Board at the Company’s 2025 annual meeting of shareholders.
Shailesh M. Kotwal will cease to serve as the Company’s Vice Chair, Payment Services, effective February 3, 2025.
Scott W. Wine notified the Board that he does not intend to stand for re-election to the Company’s Board of Directors following expiration of his current term at the Company’s 2025 Annual Meeting of Shareholders.
which reported the retirement of Matthew T. Farrell as President and Chief Executive Officer ("CEO") of the Company
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.